Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

More Effective Cancer Treatment And The Migration Of Modern Man From Africa To Western Eurasia
The Collaborative Research Centre 806 "Unser Weg nach Europa: Kultur-Umwelt-Interaktion und menschliche Mobilität im Späten Quartär" (Our Road to Europe: Culture-Environment-Interaction and human Mobility in the late Quaternary) will be directed by Professor Dr. JÃørgen of the Department of Pre- and Protohistoric Archaeology. This research centre is looking at the mobility of populations in the last 190,000 years. The focus of research will be the journey of modern man from Africa to Western Eurasia and Europe, in particular. Migration processes, and the exchange of ideas, technology and culture that entails, are an important prerequisite for important developments. The centre"s main aim is to research, using scientific and archaeological methods, how human behaviour, the climate and the environment influenced important population movements. The scientists particularly want to examine the impacts that these factors have had on the actions and reactions of populations such as emigration, immigration and adaptation to new environments. Other universities and institutions are also involved the project. These include: the University of Bonn; RWTH Aachen University; Heidelberg University; the University of Duisburg-Essen as well as the Rhineland Regional Council; the Rheinisches Amt fÃør Bodendenkmalpflege (Rheinland Department for the Preservation and Care of Field Monuments) as well as the Neanderthal Museum in Mettmann.

GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced preliminary top-line results from a Phase III study of ofatumumab administered intravenously for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to methotrexate. The study met the primary endpoint, ACR20 at 24 weeks, which indicates a 20 percent or greater improvement in the number of swollen and tender joints, as well as improvements in other disease-activity measures.
News of the day
Sanofi-Aventis, GlaxoSmithKline Will Donate Influenza Vaccines To WHO
The drugmaker Sanofi-Aventis will donate millions of doses of a vaccine that offers protection against the H1N1 (swine flu) virus to the WHO once the vaccine is ready, the company"s chief executive officer announced Tuesday, Reuters reports (Elsner, Reuters, 6/17). The AP/Google.com writes, "Exceptional times require exceptional responses. We need to act responsibly and we all have to play our part," Sanofi CEO Christopher Viehbacher said in a statement released during the Pacific Health Summit in Seattle. "This flexible donation aims to help the WHO address the needs of these most vulnerable populations," he said.
Sexual Health

U.K. City To Participate In Pilot Home-Based HIV Testing Program

The United Kingdom government has selected the city of Sheffield to participate in a three-month pilot program aimed at increasing HIV detection rates by offering home-based test kits, the Sheffield Star reports. The initiative, which will target men who have sex with men, will allow people to obtain the test kits through Web sites or community outreach centers. To take the HIV test, individuals must take a mouth swab and send it to a laboratory for testing. The lab then confidentially notifies the individual of the test results with a call or text message, Steve Slack, director of Sheffield"s Centre for HIV and Sexual Health, said. The city aims to launch the program in June. According to the Star, Sheffield is the only city in the northern part of the country to be included in the pilot program.Nearly one-third of HIV-positive U.K. residents are unaware of their status and therefore not accessing early treatment, the Star reports. Slack said the pilot program will be "an unrivalled way to engage with hard-to-reach communities to encourage more people to come forward for testing." He added that the "great thing" about home-based testing is its "ease" and that it is "completely confidential." Christine Bowman, consultant physician at Sheffield Teaching Hospitals, said, "HIV testing is not something people should be afraid to come forward for." She added, "Thousands of people in the U.K. are tested each year, but we would like to test more" (Lahive, Sheffield Star, 5/21). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009